Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study

Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications

(2021) Yongjun Wang   JOURNAL OF INVESTIGATIVE MEDICINE

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease

(2020) Jakob Schroder et al.   Journal of the American Heart Association

China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations

(2020) Yong-Jun Wang et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Anticytokine Agents

(2019) Paul M Ridker   CIRCULATION RESEARCH

The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics

(2019) Yongjun Wang et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

(2019) Jean-Claude Tardif et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic impact of Interleukin-1 receptor antagonist in patients with documented coronary artery disease

(2018) Niklas Schofer et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Long‐Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta‐Analysis

(2018) Marion Boulanger et al.   Journal of the American Heart Association

Anti-inflammatory approaches to ischaemic stroke prevention

(2017) Peter J Kelly et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Interleukin-1 Beta as a Target for Atherosclerosis Therapy

(2017) Peter Libby   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks

(2017) Peter Ganz et al.   STROKE

Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General PopulationSignificance

(2016) Alisa D. Kjaergaard et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Inflammatory Markers and Outcomes After Lacunar Stroke

(2016) Amelia K. Boehme et al.   STROKE

High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome

(2016) Jiejie Li et al.   STROKE

Chitosan leads to downregulation of YKL-40 and inflammasome activation in human macrophages

(2015) Steinunn Gudmundsdottir et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke

(2015) Samaneh Maysami et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke

(2015) Jinxi Lin et al.   NEUROLOGY

Elevated Plasma YKL-40, Lipids and Lipoproteins, and Ischemic Vascular Disease in the General Population

(2015) Alisa D. Kjaergaard et al.   STROKE

Interleukin-1 receptor antagonist: friend or foe to the heart?

(2015) Christian Herder et al.   Lancet Diabetes & Endocrinology

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis

(2015)   Lancet Diabetes & Endocrinology

Inflammation and Atherosclerosis

(2014) Joshua Hartman et al.   Cardiology in Review

Plasma Levels of the Proinflammatory Chitin‐Binding Glycoprotein YKL‐40, Variation in the Chitinase 3‐Like 1 Gene ( CHI3L1 ), and Incident Cardiovascular Events

(2014) Paul M Ridker et al.   Journal of the American Heart Association

THRIVE Score Predicts Ischemic Stroke Outcomes and Thrombolytic Hemorrhage Risk in VISTA

(2013) Alexander C. Flint et al.   STROKE

Coexisting Carotid Atherosclerosis in Patients with Intracranial Small- or Large-Vessel Disease

(2012) Ka Won Jung et al.   Journal of Clinical Neurology

Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients

(2012) Hyun Young Park et al.   PLoS One

Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury

(2011) Chun Geun Lee et al.   Annual Review of Physiology

Astrocyte and Macrophage Regulation of YKL-40 Expression and Cellular Response in Neuroinflammation

(2011) Dafna Bonneh-Barkay et al.   BRAIN PATHOLOGY

A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers

(2011) M. Faibish et al.   MOLECULAR CANCER THERAPEUTICS

Validation of the Essen Stroke Risk Score and the Stroke Prognosis Instrument II in Chinese Patients

(2011) Xia Meng et al.   STROKE

Elevated plasma YKL-40 levels and ischemic stroke in the general population

(2010) Alisa D. Kjaergaard et al.   ANNALS OF NEUROLOGY

Association of Circulating Inflammatory Markers With Recurrent Vascular Events After Stroke

(2010) William Whiteley et al.   STROKE

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease

(2009) J. Kastrup et al.   EUROPEAN HEART JOURNAL

Lipoprotein-Associated Phospholipase A 2 and C-Reactive Protein for Risk-Stratification of Patients With TIA

(2009) Brett L. Cucchiara et al.   STROKE

Inflammation and Cardiovascular Disease

(2008) William F. Fearon et al.   CIRCULATION

The Essen Stroke Risk Score Predicts Recurrent Cardiovascular Events

(2008) Christian Weimar et al.   STROKE